Member Info for crumbs

And another http://www.pharmatimes.com/news/janssen_acquires_benevir_biopharm_to_advance_immunotherapy_regimens_1234253

So that would make it June as predicted...good good let's hope all goes smoothly now

Sweet spot

Yes that helps and I'm sure many up and coming immunologists want to work with her... but I meant more like our tie-up with ISA etc LD always on the lookout for those that could enhance our own pipelines and maybe one day add to them too... hopefully we will hear some more about the new platform it might even get a name... and also potential nano delivery of ImmunoBody...

Page 4, The Cancer Immunity Cycle as created by our good friends from Genentech...and that is what it is all about. http://www.scancell.co.uk/file-manager/PDFs/scancell-presentation-feb18v2.pdf

It may be a signal of a more rational science-based approach to combos instead of we have this and this lets see what happens...$millions squandered down the line and patients getting no benefit and suddenly they realise oh maybe we should have actually asked an immunologist before we began the trial..... Always said LD should have a just call Lindy service she would save pharma $millions and make them $billions.... notice she is not only a caller of failures but she can spot winners too and also she is quite the talent scout I have no doubt if we had $billions we would be bringing in some rather impressive talents and techs that no one else would have seen first...

Well, all my funds have been taken out of my account so now just a waiting game to see if I got all of what I asked for...then onwards and upwards :)

All super duper exciting but huge costs and terrible risks when it goes wrong... I found this Fierce article and the work these guys at Boston Uni are up to with CAR T v2... they have managed to raise $53 million to create a company to take their tech into trial... but this quote says it all: 'And there's another challenge that makes it difficult to apply CAR-T technology to other cancer types, like solid tumors. "It's hard to find the one magic bullet marker on a cancer cell that is not found in any other cell type. The challenge is how to find cancer cells and kill them without killing anything else," Wong said. Hello moditope this is what BioNtech are using moditope for to make 'safe' personalised cell therapies... it recognises only cancer it is a magic key . https://www.fiercebiotech.com/research/car-t-2-0-a-split-universal-and-programmable-system As has been said here before our science is years ahead and we only hear things months down the line... goodness knows what else is going on! It will get recognised though I'm sure :)

The ambition to cure all cancer is a massive one that has always failed however we see with the event of immunotherapy the potential of achieving simply because the immune system is always curing cancer it is when it stops either to do with a fault with itself or most commonly due to cancer having evolved to evade it that we get cancer as we all know and dread by so by making cancer naked again to the immune system and or educating the immune system to hunt down targeted cancer we are seeing it is possible to readdress the imbalance....It is still early days but to me it looks like scancells tech are next stage therapies CI have kicked the doors open but will not at least by themselves be the treatments of the future ImmunoBodies and Moditopes and whatever the new platform gets named very well maybe though...

Taken up all mine plus 1k more be interesting to see if it does better than the last one

C7 obviously has not done his job you need to be in here now!☺ 3 trials about to begin from 2 platforms in at least 5 cancer target's data flowing in from next year....We only need one hit to be a commercial success but the science says we may well do much much better☺

Still an appetite for scancell shares could not be bothered getting any sub 12p myself as the fees mean may as well ask for more 12p OOs that are free of fees and better for scancell reckon once it's out the way we may get back to challenging 20p.... News flow to be expected too

No one invests in the best tech these days! Well apart from us of course

Thing is for sure all the money will be spent in the interests of scancell and will only add to IP...LD is a scientist with an ambition to beat cancer that is what she lives and breathes its not about making millions for her but in beating cancer she will make the millions... JC has his 2 million cheap shares now so hopefully next stage that commercial action we have been told to expect...

I'm thinking we will hear more about that this year and maybe soon

That confused me too ,cheers

Im still supposing that will come as a moditope deal/s waiting on the patent... and we ran out of time waiting as SCIB1 combo has to go into trial now also we are all systems go with modi trial ...drug being manufactured ...If I were scancell I'd be giving more info out about our new platform... bit of pr now would do OO take up no harm methinks

Possibly but might not be until June...be interesting if it did arrive this week :)

The Russians

Read for any with a few minutes 'If you live long enough you will get Cancer' ... which is why scancells work is of such importance to echo Krafty but also why this could well be the share not to be out of 3 trials all happening now in at least 5 targets though I have suspicion modi 1 will gain another!! data in next year its taking a while for that to sink in but I'm really beginning to warm to it as that will make next year the most 'pivotal' year for us we get to know is ImmunoBody keytruda and its rivals best combo buddy plus it gets into the hands of all the right peoiple we want it to be in.... the best clinicians in the field... and we get to know how well moditope is going to perform in patients as in we get a strong indication of does scancell hold the best keys to unlocking all cancers ....cold to hot.... for any sideliners or newbies this now has to look extremly tempting which is why I'm not too sure we will drop below 12p now though I'm ready if we do....anyways here is the article: https://www.theguardian.com/society/2018/apr/22/cancer-mutations-and-the-facts-of-life-evolution-oncogene-robert-weinberg We better hope scancell has the keys for our own sakes!